318 related articles for article (PubMed ID: 35073914)
1. Engineering of small-molecule lipidic prodrugs as novel nanomedicines for enhanced drug delivery.
Huang L; Yang J; Wang T; Gao J; Xu D
J Nanobiotechnology; 2022 Jan; 20(1):49. PubMed ID: 35073914
[TBL] [Abstract][Full Text] [Related]
2. Dimeric prodrug-based nanomedicines for cancer therapy.
Li S; Shan X; Wang Y; Chen Q; Sun J; He Z; Sun B; Luo C
J Control Release; 2020 Oct; 326():510-522. PubMed ID: 32721523
[TBL] [Abstract][Full Text] [Related]
3. Lipidic prodrug approach for improved oral drug delivery and therapy.
Markovic M; Ben-Shabat S; Keinan S; Aponick A; Zimmermann EM; Dahan A
Med Res Rev; 2019 Mar; 39(2):579-607. PubMed ID: 30320896
[TBL] [Abstract][Full Text] [Related]
4. Supramolecular nanomedicines through rational design of self-assembling prodrugs.
Wang H; Monroe M; Leslie F; Flexner C; Cui H
Trends Pharmacol Sci; 2022 Jun; 43(6):510-521. PubMed ID: 35459589
[TBL] [Abstract][Full Text] [Related]
5. Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy.
Yang K; Yang Z; Yu G; Nie Z; Wang R; Chen X
Adv Mater; 2022 Feb; 34(6):e2107434. PubMed ID: 34693571
[TBL] [Abstract][Full Text] [Related]
6. The prospects of lipidic prodrugs: an old approach with an emerging future.
Dahan A; Markovic M; Aponick A; Zimmermann EM; Ben-Shabat S
Future Med Chem; 2019 Oct; 11(19):2563-2571. PubMed ID: 31633401
[TBL] [Abstract][Full Text] [Related]
7. Small-Molecule Prodrug Nanoassemblies: An Emerging Nanoplatform for Anticancer Drug Delivery.
Li G; Sun B; Li Y; Luo C; He Z; Sun J
Small; 2021 Dec; 17(52):e2101460. PubMed ID: 34342126
[TBL] [Abstract][Full Text] [Related]
8. Stimuli-responsive prodrug-based cancer nanomedicine.
Xie A; Hanif S; Ouyang J; Tang Z; Kong N; Kim NY; Qi B; Patel D; Shi B; Tao W
EBioMedicine; 2020 Jun; 56():102821. PubMed ID: 32505922
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy agent-unsaturated fatty acid prodrugs and prodrug-nanoplatforms for cancer chemotherapy.
Sun B; Luo C; Cui W; Sun J; He Z
J Control Release; 2017 Oct; 264():145-159. PubMed ID: 28844757
[TBL] [Abstract][Full Text] [Related]
10. Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine.
Luo C; Sun J; Sun B; Liu D; Miao L; Goodwin TJ; Huang L; He Z
Small; 2016 Dec; 12(46):6353-6362. PubMed ID: 27689847
[TBL] [Abstract][Full Text] [Related]
11. Self-assembling prodrug nanotherapeutics for synergistic tumor targeted drug delivery.
Wang Z; Chen J; Little N; Lu J
Acta Biomater; 2020 Jul; 111():20-28. PubMed ID: 32454086
[TBL] [Abstract][Full Text] [Related]
12. Cancer Nanomedicines Stabilized by π-π Stacking between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug Combinations.
Wang H; Chen J; Xu C; Shi L; Tayier M; Zhou J; Zhang J; Wu J; Ye Z; Fang T; Han W
Theranostics; 2017; 7(15):3638-3652. PubMed ID: 29109766
[TBL] [Abstract][Full Text] [Related]
13. Strategies on the development of small molecule anticancer drugs for targeted therapy.
Lu YH; Gao XQ; Wu M; Zhang-Negrerie D; Gao Q
Mini Rev Med Chem; 2011 Jun; 11(7):611-24. PubMed ID: 21699492
[TBL] [Abstract][Full Text] [Related]
14. Lipid prodrug nanocarriers in cancer therapy.
Mura S; Bui DT; Couvreur P; Nicolas J
J Control Release; 2015 Jun; 208():25-41. PubMed ID: 25617724
[TBL] [Abstract][Full Text] [Related]
15. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency.
Lin MH; Hung CF; Hsu CY; Lin ZC; Fang JY
Future Med Chem; 2019 Aug; 11(16):2131-2150. PubMed ID: 31538520
[TBL] [Abstract][Full Text] [Related]
16. Block copolymer prodrugs: Synthesis, self-assembly, and applications for cancer therapy.
Dutta D; Ke W; Xi L; Yin W; Zhou M; Ge Z
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1585. PubMed ID: 31452353
[TBL] [Abstract][Full Text] [Related]
17. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.
Li Y; Lu H; Liang S; Xu S
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440
[TBL] [Abstract][Full Text] [Related]
18. Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines.
Fattahi N; Shahbazi MA; Maleki A; Hamidi M; Ramazani A; Santos HA
J Control Release; 2020 Oct; 326():556-598. PubMed ID: 32726650
[TBL] [Abstract][Full Text] [Related]
19. Stimulus-responsive self-assembled prodrugs in cancer therapy.
Dong X; Brahma RK; Fang C; Yao SQ
Chem Sci; 2022 Apr; 13(15):4239-4269. PubMed ID: 35509461
[TBL] [Abstract][Full Text] [Related]
20. New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity.
Wang H; Lu Z; Wang L; Guo T; Wu J; Wan J; Zhou L; Li H; Li Z; Jiang D; Song P; Xie H; Zhou L; Xu X; Zheng S
Cancer Res; 2017 Dec; 77(24):6963-6974. PubMed ID: 29055017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
